心脏手术后中度主动脉瓣反流的转归
本研究纳入2004年4月至2018年6月接受冠脉搭桥、二尖瓣或主动脉瘤手术且无主动脉瓣狭窄的3289例患者,评估合并主动脉瓣反流(AR)的患病率及治疗结局。倾向评分匹配显示,未治疗的中度AR不影响长期生存,且极少需要晚期干预。
要点
- 合并中度AR者占4.2%,其中33%同期行主动脉瓣手术。
- 未治疗的中度AR不影响长期生存,10年进展至超过中度仅2.6%。
- 选择患者同期行主动脉瓣手术可附加极低风险。
核心结论
- 对合并中度AR的特定患者,同期行主动脉瓣手术可附加极小风险。
- 未治疗的中度AR不影响心脏手术后的长期生存,且极少需要晚期干预。
研究设计与样本
- 回顾性队列研究,纳入2004年4月至2018年6月接受冠脉搭桥、二尖瓣或主动脉瘤手术且无主动脉瓣狭窄的3289例患者。
- AR分级为无/微量(0分)、轻度(1+)、中度(2+);未治疗2+AR与0或1+AR及治疗2+AR比较,采用倾向评分匹配。
主要发现
- 未调整分析中,术前AR分级越低,10年生存率越高(P < .001)。
- 中度AR患者10年进展为超过中度AR的比例为2.6%,晚期干预率为3.1%。
- 未治疗2+AR组末次随访超声显示58%改善、41%仍为2+、仅1%进展为重度。
关键数值与推荐
- 2+AR患者中,二叶主动脉瓣(9% vs 0%;P < .01)、风湿性瓣膜病(16% vs 3%;P < .01)和钙化(47% vs 27%;P = .021)与更常行瓣膜手术相关。
临床怎么用
- 对合并中度AR的心脏手术患者,可考虑对特定患者(如瓣叶解剖异常)同期行主动脉瓣手术,附加风险极小。
- 未治疗的中度AR患者长期生存不受影响,晚期干预需求低,可密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence of concomitant aortic regurgitation (AR) in cardiac surgery and the outcomes of treatment options. METHODS: Between April 2004 and June 2018, 3289 patients underwent coronary artery bypass, mitral valve, or aortic aneurysm surgery without aortic stenosis. AR was graded none/trivial (score = 0), mild (score = 1+), or moderate (score = 2+). Patients with untreated 2+ AR were compared with those with 0 or 1+ AR, and to those with 2+ AR who had aortic valve surgery. Thirty-day and late survival, echocardiography, and clinical outcomes were compared using propensity score matching. RESULTS: One hundred thirty-eight patients (4.2%) had 2+ AR; and 45 (33%) received aortic valve repair (n = 9) or replacement (n = 36) in the treated group and were compared with 2765 untreated patients with 0 AR and 386 patients with 1+ AR. Valve surgery was more common with anatomic leaflet abnormalities: bicuspid aortic valve (9% vs 0%; P < .01), rheumatic valve disease (16% vs 3%; P < .01), and calcification (47% vs 27%; P = .021). In unadjusted analysis, lower preoperative AR grade was associated with increased 10-year survival (P < .001). At year 10, progression to more-than-moderate AR among moderate AR patients was 2.6% and late intervention rate was 3.1%. In the untreated 2+ AR group, on last follow-up echocardiogram, 58% had improvement in AR, 41% remained 2+, and only 1% progressed to severe AR. CONCLUSIONS: Aortic valve surgery in select patients with concomitant moderate AR can be added with minimal added risk, but untreated AR does not influence long-term survival after cardiac surgery and rarely required late intervention.
引用
- Ward A, Malaisrie SC, Andrei AC, et al. Fate of moderate aortic regurgitation after cardiac surgery. J Thorac Cardiovasc Surg. 2021. PMID: 33610367. doi:10.1016/j.jtcvs.2020.12.114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。